Development and initial testing of the stroke rapid-treatment readiness tool.
Repository Usage Stats
No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.
Early Medical Intervention
Patient Care Team
Time and Motion Studies
Tissue Plasminogen Activator
Published Version (Please cite this version)10.1097/JNN.0000000000000082
Publication InfoBritz, GW; Constable, M; Cox, M; Fonarow, GC; Lin, CB; Olson, DaiWai M; ... Zimmer, LO (2014). Development and initial testing of the stroke rapid-treatment readiness tool. J Neurosci Nurs, 46(5). pp. 267-273. 10.1097/JNN.0000000000000082. Retrieved from https://hdl.handle.net/10161/15006.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Fred Cobb, M.D. Professor of Medicine
Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical Research Institute (DCRI), Durham, NC, USA. Dr Peterson is the Principal Investigator of the National Institute of Health, Lung and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial He is also the Principal I